Morgan ML - Search Results

1

Cognitive and physiologic correlates of subclinical structural brain disease in elderly healthy control subjects.

Cook IA, Leuchter AF, Morgan ML, Conlee EW, David S, Lufkin R, Babaie A, Dunkin JJ, O'Hara R, Simon S, Lightner A, Thomas S, Broumandi D, Badjatia N, Mickes L, Mody RK, Arora S, Zheng Z, Abrams M, Rosenberg-Thompson S. Cook IA, et al. Among authors: morgan ml. Arch Neurol. 2002 Oct;59(10):1612-20. doi: 10.1001/archneur.59.10.1612. Arch Neurol. 2002. PMID: 12374500

2

Estrogen replacement therapy is associated with less progression of subclinical structural brain disease in normal elderly women: a pilot study.

Cook IA, Morgan ML, Dunkin JJ, David S, Witte E, Lufkin R, Abrams M, Rosenberg S, Leuchter AF. Cook IA, et al. Among authors: morgan ml. Int J Geriatr Psychiatry. 2002 Jul;17(7):610-8. doi: 10.1002/gps.644. Int J Geriatr Psychiatry. 2002. PMID: 12112157

3

Longitudinal progression of subclinical structural brain disease in normal aging.

Cook IA, Leuchter AF, Morgan ML, Dunkin JJ, Witte E, David S, Mickes L, O'Hara R, Simon S, Lufkin R, Abrams M, Rosenberg S. Cook IA, et al. Among authors: morgan ml. Am J Geriatr Psychiatry. 2004 Mar-Apr;12(2):190-200. Am J Geriatr Psychiatry. 2004. PMID: 15010348

4

Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placebo.

Hunter AM, Leuchter AF, Morgan ML, Cook IA, Abrams M, Siegman B, DeBrota DJ, Potter WZ. Hunter AM, et al. Among authors: morgan ml. Neuropsychopharmacology. 2005 Apr;30(4):792-9. doi: 10.1038/sj.npp.1300652. Neuropsychopharmacology. 2005. PMID: 15637637 Clinical Trial.

5

Influence of age, gender, health status, and depression on quantitative EEG.

Morgan ML, Witte EA, Cook IA, Leuchter AF, Abrams M, Siegman B. Morgan ML, et al. Neuropsychobiology. 2005;52(2):71-6. doi: 10.1159/000086608. Epub 2005 Jun 29. Neuropsychobiology. 2005. PMID: 15990459

6

Neurophysiologic changes during estrogen augmentation in perimenopausal depression.

Morgan ML, Cook IA, Rapkin AJ, Leuchter AF. Morgan ML, et al. Maturitas. 2007 Jan 20;56(1):54-60. doi: 10.1016/j.maturitas.2006.05.010. Epub 2006 Jul 10. Maturitas. 2007. PMID: 16835012 Clinical Trial.

7

Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression.

Hunter AM, Leuchter AF, Morgan ML, Cook IA. Hunter AM, et al. Among authors: morgan ml. Am J Psychiatry. 2006 Aug;163(8):1426-32. doi: 10.1176/ajp.2006.163.8.1426. Am J Psychiatry. 2006. PMID: 16877657 Clinical Trial.

8

Changes in brain function during administration of venlafaxine or placebo to normal subjects.

Leuchter AF, Cook IA, DeBrota DJ, Hunter AM, Potter WZ, McGrouther CC, Morgan ML, Abrams M, Siegman B. Leuchter AF, et al. Among authors: morgan ml. Clin EEG Neurosci. 2008 Oct;39(4):175-81. doi: 10.1177/155005940803900405. Clin EEG Neurosci. 2008. PMID: 19044214 Clinical Trial.

9

Changes in brain function of depressed subjects during treatment with placebo.

Leuchter AF, Cook IA, Witte EA, Morgan M, Abrams M. Leuchter AF, et al. Am J Psychiatry. 2002 Jan;159(1):122-9. doi: 10.1176/appi.ajp.159.1.122. Am J Psychiatry. 2002. PMID: 11772700 Clinical Trial.

10

Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression.

Leuchter AF, Morgan M, Cook IA, Dunkin J, Abrams M, Witte E. Leuchter AF, et al. Psychopharmacology (Berl). 2004 Dec;177(1-2):15-22. doi: 10.1007/s00213-004-1919-2. Epub 2004 Jul 14. Psychopharmacology (Berl). 2004. PMID: 15252704 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters